← All trials
NCT01791985
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2012
- Primary completion
- Nov 1, 2016
- Completion date
- Jun 1, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 56
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- University of LondonLead sponsor
- The Christie NHS Foundation TrustOverall official - principal investigator
- University of GlasgowOverall official - principal investigator
- University of LondonOverall official - principal investigator
- Poole Hospital NHS Foundation TrustOverall official - principal investigator
- Burton Hospitals NHS Foundation TrustOverall official - principal investigator
- The Dudley Group NHS Foundation TrustOverall official - principal investigator
- Cancer Research UKCollaborator
- AstraZenecaCollaborator
- University of CambridgeOverall official - principal investigator
- Newcastle UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.